Smith 1994.
Methods | Multi‐centre, parallel‐group study | |
Participants | 220 patients aged 18‐70 | |
Interventions | Tizanidine (2‐36mg) v. placebo | |
Outcomes | Primary end‐points: Ashworth score, patient diaries (muscle spasm & clonus scores). Secondary end‐points: reflexes, clonus, spasms (assessed by physician), muscle power (MRC grade), walking time, ADL, global evaluation of efficacy | |
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment? | Unclear risk | B ‐ Unclear |